IP Library Granted Patent US 12,606,573
Granted Patent B2
US 12,606,573 · App. 18/248,176 · Granted Apr 21, 2026

Process for boron-containing compounds

Inventor: Julian Rudolf Kuttner (Hessen, DE)
Assignee: VENATORX PHARMACEUTICALS, INC.
C07F5/025
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,606,573
App. No.
18/248,176
Granted
Apr 21, 2026
Kind
B2
Abstract

Described herein are boron-containing compounds, compositions, and methods for their preparation.

Claims (76)

1 . A process for preparing a compound of Formula (III):

wherein:

P 1 is a hydroxyl protecting group; and

R a , R b , and R c are independently hydrogen, fluoro, or chloro;

the process comprising reacting a compound of Formula (II)

 with an oxidizing agent.

2 . The process of claim 1 , wherein the oxidizing agent is potassium permanganate (KMnO 4 ).

3 . The process of claim 1 , wherein the process further comprises a base.

4 . The process of claim 1 , wherein the process comprises:

(i) suspending the compound of Formula (II):

 in water;

(ii) adding a base to dissolve the compound of Formula (II) in water;

(iii) adding an oxidizing agent while stirring;

(iv) stirring;

(v) adding a solvent to inactivate the excess oxidizing agent;

(vi) stirring;

(vii) filtering to get a filtrate;

(viii) acidifying the filtrate to get a slurry;

(viii) cooling the slurry; and

(ix) filtering the slurry thereby obtaining the compound of Formula (III):

5 . The process of claim 4 , wherein:

(a) the base in step (ii) is sodium hydroxide;

(b) the oxidizing agent is potassium permanganate (KMnO 4 );

(c) step (iii) is performed for about 10 h to about 20 h;

(d) the temperature is maintained at between about 20° C. and about 30° C. in step (iii);

(e) the solvent to inactivate the excess oxidizing agent is a primary or secondary alcoholic solvent;

(f) step (vi) is performed for about 10 min to about 2 h;

(g) the filtrate obtained in step (vii) is cooled to between about 0° C. and about 10° C. in step (viii) prior to acidifying;

(h) the acid used for acidifying is sulfuric acid; and/or

(i) the compound of Formula (III) is obtained by filtration.

6 . The process of claim 1 , wherein the compound of Formula (II):

is obtained by reacting a compound of Formula (I):

with a lithium reagent followed by a borate.

7 . The process of claim 6 , wherein the compound of Formula (I) is contacted with the lithium reagent to form a compound of Formula (Ia):

8 . The process of claim 6 , wherein the lithium reagent is n-BuLi.

9 . The process of claim 6 , wherein the borate is B(OiPr) 3 .

10 . The process of claim 6 , wherein the process comprises:

(i) combining a compound of Formula (I):

 and a diamine in a solvent;

(ii) stirring;

(iii) adding a lithium reagent;

(iv) stirring;

(v) adding a borate;

(vi) quenching the reaction by adding an aqueous acidic solution;

(vii) separating the layers to obtain an organic layer;

(viii) adding an aqueous basic solution to the organic layer;

(ix) separating the layers to obtain an aqueous layer;

(x) adding an acid to the aqueous layer;

(xi) cooling to obtain a suspension;

(xii) stirring;

(xiii) filtering the suspension, thereby obtaining the compound of Formula (II):

11 . The process of claim 10 , wherein:

(a) the diamine is TMEDA;

(b) the solvent use in step (i) is cyclohexane;

(c) the lithium reagent is nBuLi;

(d) the borate is B(OiPr) 3 ;

(e) the addition of the lithium reagent in step (iii) is done over about 1 h to about 6 h;

(f) the addition of the lithium reagent in step (iii) is done while the temperature is maintained between about 0° C. and about 20° C.;

(g) step (iv) is performed for about 2 h to about 3 h;

(h) the temperature is cooled to below −70° C. prior to the addition of the borate in step (v);

(i) the temperature is warmed to above −20° C. after to the addition of the borate in step (v);

(j) the aqueous acidic solution in step (vi) is a HCl solution;

(k) the aqueous basic solution in step (viii) is a NaOH solution; and/or

(l) the cooling temperature in step (xi) is about 0° C. and about 5° C.

12 . The process of claim 1 , further comprising reacting the compound of Formula (III):

with (1S,2S,3R,5S)-(+)-pinanediol in a solvent to form a compound of Formula (IV):

13 . The process of claim 12 , wherein the process comprises:

(i) mixing the compound of Formula (III), (1S,2S,3R,5S)-(+)-pinanediol, and the solvent;

(ii) heating the resulting mixture;

(iii) cooling to obtain a slurry;

(iv) filtering to obtain the compound of Formula (IV).

14 . The process of claim 13 , wherein:

(a) the solvent is n-heptane;

(b) the heating is done to reach reflux;

(c) step (ii) further comprises removing water; and/or

(d) the cooling temperature in step (iii) is below about 60° C.

Assignments (3)
LICENSE Recorded Feb 11, 2026
From: VENATORX PHARMACEUTICALS, INC.
To: NATIONAL INSTITUTES OF HEALTH
Reel/Frame 074766/0037 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 13, 2023
From: CURIA GLOBAL, INC.
To: VENATORX PHARMACEUTICALS, INC.
Reel/Frame 063315/0042 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 13, 2023
From: KUTTNER, JULIAN RUDOLF
To: CURIA GLOBAL, INC.
Reel/Frame 063692/0567 →
Continuity (2)
Provisional Application 63088872 · Oct 7, 2020
Related Publication 20240092807A1 · Mar 21, 2024
References Cited (35)
US 8912169B2 · Burns et al. · 2014 [cited by applicant]
US 9422314B2 · Burns et al. · 2016 [cited by applicant]
US 9637504B2 · Burns et al. · 2017 [cited by applicant]
US 9783555B2 · Burns et al. · 2017 [cited by applicant]
US 9828391B2 · Burns et al. · 2017 [cited by applicant]
US 9926336B2 · Burns et al. · 2018 [cited by applicant]
US 10214547B2 · Burns et al. · 2019 [cited by applicant]
US 10669290B2 · Burns et al. · 2020 [cited by applicant]
US 10889600B2 · Amann et al. · 2021 [cited by applicant]
US 11008346B2 · Burns et al. · 2021 [cited by applicant]
US 11267826B2 · Burns et al. · 2022 [cited by applicant]
US 11560392B2 · Amann et al. · 2023 [cited by applicant]
US 20100120715A1 · Burns et al. · 2010 [cited by applicant]
US 20100286092A1 · Burns et al. · 2010 [cited by applicant]
US 20100292185A1 · Burns et al. · 2010 [cited by applicant]
US 20100317621A1 · Burns et al. · 2010 [cited by applicant]
US 20190048027A1 · Wu et al. · 2019 [cited by applicant]
US 20200095217A1 · Dowdell et al. · 2020 [cited by applicant]
US 20200102331A1 · Burns et al. · 2020 [cited by applicant]
CN 105801610A · 2016 [cited by applicant]
CN 106946924A · 2017 [cited by applicant]
WO WO2009064413A1 · 2009 [cited by applicant]
WO WO2009064414A1 · 2009 [cited by applicant]
WO WO2010056827A1 · 2010 [cited by applicant]
WO WO2010130708A1 · 2010 [cited by applicant]
WO WO2014089365A1 · 2014 [cited by applicant]
WO WO2015191907A1 · 2015 [cited by applicant]
WO WO2017044828A1 · 2017 [cited by applicant]
WO WO2018027062A1 · 2018 [cited by applicant]
WO WO2018218190A1 · 2018 [cited by applicant]
WO WO2022076070A1 · 2022 [cited by applicant]
PCT/US2021/044808 International Search Report and Written Opinion dated Nov. 10, 2021. [cited by applicant]
Slocum et al. Metalation of o-methylanisole (o-MA); an optional-site selectivity reassessment. Tetrahedron 66(27-28):4939-4942 (2010). [cited by applicant]
Krajnc, Alen et al. Bicyclic boronate VNRX-5133 inhibits metallo-and serine-β-lactamases. Journal of Medicinal Chemistry 62(18):8544-8556 (2019). [cited by applicant]
Kurach, Paweł. et al. One-Pot Generation of Lithium (Lithiophenyl) trialkoxyborates from Substituted Dihalobenzenes (Hal=Br, I) and Their Derivatization with Electrophiles. European Journal of Organic Chemistry 2008(18)… [cited by applicant]